Monovalent Omicron COVID-19 vaccine triggers superior neutralizing antibody responses against Omicron subvariants than Delta and Omicron bivalent vaccine

The continuous evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants poses a challenge to determine the optimal updated composition of the coronavirus disease 2019 (COVID-19) vaccine. The present study aimed to investigate the immunogenicity of the Delta monovalent vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wanting, Zhao, Tiantian, Tao, Bai, Zhao, Liwei, Xiao, Hang, Ding, Xinyu, Li, Chuang, Chen, Lin, Cheng, Hao, Lou, Yang, Chen, Yuxin, Wu, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583637/
https://www.ncbi.nlm.nih.gov/pubmed/37846840
http://dx.doi.org/10.1080/21645515.2023.2264589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583637/
https://www.ncbi.nlm.nih.gov/pubmed/37846840
http://dx.doi.org/10.1080/21645515.2023.2264589

Ejemplares similares